Alloimmune Platelet Refractoriness
1 clinical trials · Condition
◉ Watch Alloimmune Platelet Refractoriness
| Record | Firm | Date |
|---|---|---|
| Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia (NCT02298933) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-11-21 |
Track Alloimmune Platelet Refractoriness automatically
Every clearance here is in the API, with alerts when new ones post.